Soft Tissue Infections
Studies from D.L. Anderson and co-authors have provided new information about soft tissue infections
Published in Pharma Law Weekly, December 23rd, 2008
"Oritavancin (LY-333328) is a semisynthetic lipoglycopeptide for the treatment of serious infections with Gram-positive pathogens, especially methicillin-resistant Staphylococcus aureus and complicated skin and soft tissue infections. A New Drug Application for oritavancin administered intravenously once daily for 3 to 7 days for complicated skin and soft tissue infections was filed with the U.S.," scientists in Barcelona, Spain report.
"Food and Drug Administration in April 2008. This article provides an overview of the publicly available data and includes data presented at the European Congress of Clinical Microbiology and Infectious Disease in April 2008. Although...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2008-12-23)
More Articles from Pharma Law Weekly
- Accertify
1-800-FLOWERS.COM Selects Accertify for Online Fraud Prevention - Adecco Group North America
Statement by Tig Gilliam, CEO of Adecco Group North America, on November's Bureau of Labor Statistics Jobs Report - ALCS
Ensuring a Fair Deal for Writers: All Party Writers Group Calls for Update to PLR Legislation - Alternative and Complementary Medicine
Investigators at Massachusetts General Hospital zero in on alternative and complementary medicine - Alternative and Complementary Medicine
Investigators at University of York target alternative and complementary medicine - American Cancer Society
State policies have little effect on reducing minors' indoor tanning use - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
